Evidence map›Paper›PMID 32110371›Full record

ArticleChemical science2020

Novel four-disulfide insulin analog with high aggregation stability and potency.

Xiaochun Xiong, Alan Blakely, Prasoona Karra, Michael A VandenBerg, Gabrielle Ghabash, Frank Whitby, Yi Wolf Zhang, Matthew J Webber, William L Holland, Christopher P Hill and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xiaochun XiongDepartment of Biochemistry , University of Utah , Salt Lake City UT 84112 , USA . Email: chris@biochem.utah.edu ; Email: dchou@biochem.utah.edu.ORCID 0000-0003-2998-7032
Alan BlakelyDepartment of Biochemistry , University of Utah , Salt Lake City UT 84112 , USA . Email: chris@biochem.utah.edu ; Email: dchou@biochem.utah.edu.ORCID 0000-0002-8066-7870
Prasoona KarraDepartment of Nutrition and Integrative Physiology , University of Utah , Salt Lake City UT 84112 , USA.
Michael A VandenBergDepartment of Chemical & Biomolecular Engineering , University of Notre Dame , IN 46556 , USA.
Gabrielle GhabashDepartment of Biochemistry , University of Utah , Salt Lake City UT 84112 , USA . Email: chris@biochem.utah.edu ; Email: dchou@biochem.utah.edu.
Frank WhitbyDepartment of Biochemistry , University of Utah , Salt Lake City UT 84112 , USA . Email: chris@biochem.utah.edu ; Email: dchou@biochem.utah.edu.
Yi Wolf ZhangDepartment of Biochemistry , University of Utah , Salt Lake City UT 84112 , USA . Email: chris@biochem.utah.edu ; Email: dchou@biochem.utah.edu.
Matthew J WebberDepartment of Chemical & Biomolecular Engineering , University of Notre Dame , IN 46556 , USA.ORCID 0000-0003-3111-6228
William L HollandDepartment of Nutrition and Integrative Physiology , University of Utah , Salt Lake City UT 84112 , USA.
Christopher P HillDepartment of Biochemistry , University of Utah , Salt Lake City UT 84112 , USA . Email: chris@biochem.utah.edu ; Email: dchou@biochem.utah.edu.ORCID 0000-0001-6796-7740
Danny Hung-Chieh ChouDepartment of Biochemistry , University of Utah , Salt Lake City UT 84112 , USA . Email: chris@biochem.utah.edu ; Email: dchou@biochem.utah.edu.ORCID 0000-0001-9110-614X
University of Utah · USUniversity of Notre Dame · US

Funding

DEVELOPMENT OF CONCENTRATED, STABLE ULTRA FAST-ACTING INSULIN FORMULATIONR01DK120430 · NIDDK · UNIVERSITY OF UTAH · PI CHOU, DANNY HUNG-CHIEH · 2018 to 2021
$2.2M
NIDDK NIH HHS R01 DK120430
6 · The paper itself

Abstract

Although insulin was first purified and used therapeutically almost a century ago, there is still a need to improve therapeutic efficacy and patient convenience. A key challenge is the requirement for refrigeration to avoid inactivation of insulin by aggregation/fibrillation. Here, in an effort to mitigate this problem, we introduced a 4

Identifiers

PMID32110371
PMCPMC7012051
OpenAlexW2987294264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.